Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
11, 18 These are usually transient and improve with continued treatment
Role of advanced glycation end products and mitohormesis in cancer development and progression
Coskun et al., LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept, Mol
This increased metabolic activity during protein digestion actually produces a mild energizing effect rather than the drowsiness that often follows carbohydrate-heavy meals
10.1152/ajpcell.1998.275.3.C675 112
Trends Biotechnol (2003) 21(12):55662
US$ 28.96
US$ 25.24
US$ 23.80
US$ 20.88
US$ 28.40
US$ 24.69
